Professional Summary

Professional Overview

Jim Hippel is the Executive Vice President and Chief Financial Officer at Bio-Techne, a leading developer and manufacturer of high-quality reagents and instruments for the life science and diagnostic markets. With over 25 years of experience in finance and operations, he brings a wealth of expertise in driving strategic growth and enhancing financial performance within the biotechnology and life sciences industries.

Experience Summary

Current Role

As the Executive Vice President and Chief Financial Officer at Bio-Techne, Jim is responsible for overseeing the company's financial operations, including financial planning and analysis, accounting, treasury, and investor relations. He plays a crucial role in supporting the company's global expansion and driving continuous improvement in financial processes and controls. Under his leadership, Bio-Techne has achieved consistent revenue and profitability growth, positioning the company as a leading player in the biotechnology sector.

Career Progression

Prior to joining Bio-Techne, Jim held various finance leadership roles at prominent organizations within the life sciences and aerospace industries. He served as the Chief Financial Officer at Mirion Technologies, Inc., where he led the successful integration of two acquired businesses and helped the company achieve significant operational and financial improvements. Before that, he held the position of Vice President of Finance, Chromatography & Mass Spec at Thermo Fisher Scientific, where he was instrumental in driving the division's strategic initiatives and enhancing its operational efficiency. Jim's early career experience includes serving as a Supervising Senior at KPMG Peat Marwick, where he gained valuable insights into financial reporting and auditing practices.

Academic Background

Jim holds a Bachelor of Science degree in Accounting from the University of Minnesota, where he graduated with distinction.

Areas of Expertise

• Financial planning and analysis

• Mergers and acquisitions

• Operational excellence and cost optimization

• Strategic decision-making

• Financial reporting and compliance

• Investor relations and communication

Professional Impact

Under Jim's leadership, Bio-Techne has consistently delivered strong financial performance, with double-digit revenue and earnings growth. He has played a pivotal role in the company's strategic initiatives, including the successful integration of several acquisitions, which have expanded Bio-Techne's product portfolio and market reach. Jim's keen financial acumen and strategic vision have contributed to the company's positioning as a trusted partner in the life sciences industry.

Conclusion

With his extensive experience in the biotechnology and life sciences sectors, Jim Hippel is a seasoned finance executive who has demonstrated a track record of driving growth, improving operational efficiency, and delivering consistent financial performance. As the Executive Vice President and Chief Financial Officer at Bio-Techne, he continues to contribute to the company's success and solidify its position as a leader in the industry.